Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of cell cycle regulator proteins in non-small cell lung cancer.
Esposito V, Baldi A, Tonini G, Vincenzi B, Santini M, Ambrogi V, Mineo TC, Persichetti P, Liuzzi G, Montesarchio V, Wolner E, Baldi F, Groeger AM. Esposito V, et al. Among authors: montesarchio v. J Clin Pathol. 2004 Jan;57(1):58-63. doi: 10.1136/jcp.57.1.58. J Clin Pathol. 2004. PMID: 14693837 Free PMC article.
Analysis of Fas (Apo-1/CD95) expression in non-small cell lung cancer.
Esposito V, Baldi A, Liuzzi G, Tonini G, Vincenzi B, Persichetti P, Santini M, Ambrogi V, Mineo TC, Montesarchio V, Wolner E, Baldi F, Groeger AM. Esposito V, et al. Among authors: montesarchio v. Anticancer Res. 2003 Nov-Dec;23(6C):4901-5. Anticancer Res. 2003. PMID: 14981943
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study.
Di Lorenzo G, Rea A, Carlomagno C, Pepe S, Palmieri G, Labianca R, Chirianni A, De Stefano A, Esposito V, De Placido S, Montesarchio V. Di Lorenzo G, et al. Among authors: montesarchio v. World J Gastroenterol. 2007 Dec 28;13(48):6553-7. doi: 10.3748/wjg.v13.i48.6553. World J Gastroenterol. 2007. PMID: 18161926 Free PMC article. Clinical Trial.
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study.
Prete SD, Montella L, Caraglia M, Maiorino L, Cennamo G, Montesarchio V, Piai G, Febbraro A, Tarantino L, Capasso E, Palmieri G, Guarrasi R, Bianco M, Mamone R, Savastano C, Pisano A, Vincenzi B, Sabia A, D'Agostino A, Faiola V, Addeo R. Prete SD, et al. Among authors: montesarchio v. Cancer Chemother Pharmacol. 2010 Oct;66(5):837-44. doi: 10.1007/s00280-009-1226-z. Epub 2009 Dec 30. Cancer Chemother Pharmacol. 2010. PMID: 20041325 Clinical Trial.
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series.
Montella L, Addeo R, Palmieri G, Caraglia M, Cennamo G, Vincenzi B, Guarrasi R, Mamone R, Faiola V, Frega N, Capasso E, Maiorino L, Leopardo D, Pizza C, Montesarchio V, Del Prete S. Montella L, et al. Among authors: montesarchio v. Cancer Chemother Pharmacol. 2010 May;65(6):1137-43. doi: 10.1007/s00280-009-1122-6. Epub 2009 Sep 16. Cancer Chemother Pharmacol. 2010. PMID: 19760218 Clinical Trial.
99 results